Investigation of Pneumococcus, Influenza, Covid-19 Vaccination Rates and Affecting Factors in Patients aged 65 and over

Author:

Çelik Dönmez Aslıhan1ORCID,Çelik Güzel Eda2ORCID,Topçu Birol3ORCID

Affiliation:

1. NAMIK KEMAL UNIVERSITY

2. TEKİRDAĞ NAMIK KEMAL ÜNİVERSİTESİ

3. TEKIRDAG NAMIK KEMAL UNIVERSITY

Abstract

Objective: This study was planned to determine the vaccination rates and related factors with Pneumococcal, Influenza and Covid-19 vaccines in adults aged 65 and over who applied to the Family Medicine Outpatient Clinic. Methods: The sample of the descriptive study consisted of 200 volunteer adult patients aged 65 and over who applied to the Family Medicine outpatient clinic between May and October 2021. The data were collected by applying a face-to-face interview with descriptive features. Results: The mean age of the participants was 71.21±5.97 years. Influenza vaccination rate of all participants in the last 1 year was 24.50%, Pneumococcal vaccination rate in the last 5 years was 42%, and Covid-19 vaccination rate was 86%. In our study, having a chronic disease was the factor that increased the rate of influenza vaccination, it was determined that the factor determining the pneumococcal vaccination rate was affected by the habit of going to the family doctor regularly (p

Publisher

Konuralp Medical Journal

Reference13 articles.

1. 1. Nergiz EM, Yalcın SS. Eradication of Infectious Diseases and the Role of Vaccines.Turkiye Klinikleri Social Pediatrics.2021;1:20-7.

2. 2. Mutlu HH, Coskun FO, Sargın M. Vaccination Frequency and Awareness in People aged 65 and over who applied to the Family Medicine Outpatient Clinic.Ankara Medical Journal.2018;1:1‐13.

3. 3. Erdogdu HI, Oner C. Immunosenescence and The Importance of Influenza And Pneumococcal Vaccine in Elderly. TJMFPC.2019;13(4):567-72.

4. 4. CDC. Recommended Immunizations for Adults: by Age.[Internet].2021; https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf (Accessed: October 17, 2021).

5. 5. Comorbidities the CDC classifies as risk factors for severe COVID-19.[ Internet].2022; https://www.uptodate.com/contents/image?imageKey=PC%2F127477 (Accessed: January 8, 2022).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3